Systemic and Lower Respiratory Tract Immunity to SARS-CoV-2 Omicron and Variants in Pediatric Severe COVID-19 and Mis-C
暂无分享,去创建一个
A. Randolph | S. Khurana | Juanjie Tang | T. Novak | M. Zinter | Tracie Walker | K. Irby | L. Loftis | Katherine Irby | T. Walker
[1] S. Bittmann. Role of Omicron variant of SARS-CoV-2 in children in Germany , 2022, World Journal of Pediatrics.
[2] S. Mallapaty. Where did Omicron come from? Three key theories , 2022, Nature.
[3] A. Sigal. Milder disease with Omicron: is it the virus or the pre-existing immunity? , 2022, Nature Reviews Immunology.
[4] T. Ndung’u,et al. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization , 2021, Nature.
[5] P. Maes,et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization , 2021, Nature.
[6] Liyuan Liu,et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 , 2021, Nature.
[7] P. Pawłowski. SARS-CoV-2 variant Omicron (B.1.1.529) is in a rising trend of mutations increasing the positive electric charge in crucial regions of the spike protein S. , 2021, Acta biochimica Polonica.
[8] S. Karim,et al. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic , 2021, The Lancet.
[9] S. Lapp,et al. SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19 , 2021, Nature Immunology.
[10] S. Khurana,et al. Systemic and mucosal immune profiling in asymptomatic and symptomatic SARS-CoV-2–infected individuals reveal unlinked immune signatures , 2021, Science advances.
[11] B. Golding,et al. Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern , 2021, iScience.
[12] G. Di Sante,et al. Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection , 2021, The Lancet Child & Adolescent Health.
[13] D. Lauffenburger,et al. Humoral signatures of protective and pathological SARS-CoV-2 infection in children , 2021, Nature Medicine.
[14] Wei Wang,et al. Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2 , 2020, bioRxiv.
[15] Simon Li,et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents , 2020, The New England journal of medicine.
[16] O. Schwartz,et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2 , 2020, Science Translational Medicine.
[17] S. Khurana,et al. Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits , 2020, Science Translational Medicine.
[18] D. Jamison,et al. Acute Respiratory Infections in Children -- Disease Control Priorities in Developing Countries , 2006 .
[19] O. Pettay,et al. Acute Respiratory Infections in Children , 1960 .